Debt-to-equity in % of Microbot Medical Inc. from Q1 2012 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Microbot Medical Inc. quarterly Debt-to-equity history and change rate from Q1 2012 to Q3 2025.
  • Microbot Medical Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 7.62 %, a 79.9% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Microbot Medical Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 7.62 -30.4 -79.9% 30 Sep 2025
Q2 2025 12.9 -20 -60.8% 30 Jun 2025
Q1 2025 17.1 -11.9 -41.2% 31 Mar 2025
Q4 2024 33.1 +2.06 +6.63% 31 Dec 2024
Q3 2024 38 +15.4 +68% 30 Sep 2024
Q2 2024 33 +7.53 +29.6% 30 Jun 2024
Q1 2024 29 +0.43 +1.51% 31 Mar 2024
Q4 2023 31.1 +6.25 +25.2% 31 Dec 2023
Q3 2023 22.6 +1.86 +8.95% 30 Sep 2023
Q2 2023 25.4 +9.63 +61% 30 Jun 2023
Q1 2023 28.6 +16 +128% 31 Mar 2023
Q4 2022 24.8 +14.4 +138% 31 Dec 2022
Q3 2022 20.8 +12 +138% 30 Sep 2022
Q2 2022 15.8 +8.18 +107% 30 Jun 2022
Q1 2022 12.5 +5.77 +85.2% 31 Mar 2022
Q4 2021 10.5 +4.33 +70.8% 31 Dec 2021
Q3 2021 8.73 -0.12 -1.36% 30 Sep 2021
Q2 2021 7.62 -6.38 -45.6% 30 Jun 2021
Q1 2021 6.78 -15.1 -69% 31 Mar 2021
Q4 2020 6.12 -29.4 -82.8% 31 Dec 2020
Q3 2020 8.85 -66.3 -88.2% 30 Sep 2020
Q2 2020 14 -45.3 -76.4% 30 Jun 2020
Q1 2020 21.9 -22 -50.2% 31 Mar 2020
Q4 2019 35.5 +8.66 +32.3% 31 Dec 2019
Q3 2019 75.2 +68.4 +1013% 30 Sep 2019
Q2 2019 59.3 +53.5 +925% 30 Jun 2019
Q1 2019 43.9 +38.3 +682% 31 Mar 2019
Q4 2018 26.8 +18.3 +215% 31 Dec 2018
Q3 2018 6.75 -6.28 -48.2% 30 Sep 2018
Q2 2018 5.78 -37.9 -86.7% 30 Jun 2018
Q1 2018 5.62 -428 -98.7% 31 Mar 2018
Q4 2017 8.51 +628 31 Dec 2017
Q3 2017 13 +493 30 Sep 2017
Q2 2017 43.7 +829 30 Jun 2017
Q1 2017 433 +1.52K 31 Mar 2017
Q4 2016 -620 +3.32K +84.2% 31 Dec 2016
Q3 2016 -480 +11.4K +96% 30 Sep 2016
Q2 2016 -785 -1.46K -216% 30 Jun 2016
Q1 2016 -1.09K -2.01K -218% 31 Mar 2016
Q4 2015 -3.93K -4.46K -852% 31 Dec 2015
Q3 2015 -11.9K -12.4K -2325% 30 Sep 2015
Q2 2015 676 -599 -47% 30 Jun 2015
Q1 2015 923 +383 +71% 31 Mar 2015
Q4 2014 523 +108 +25.9% 31 Dec 2014
Q3 2014 535 +303 +131% 30 Sep 2014
Q2 2014 1.28K +1.09K +603% 30 Jun 2014
Q1 2014 540 +378 +233% 31 Mar 2014
Q4 2013 416 +199 +92.2% 31 Dec 2013
Q3 2013 232 -3.65 -1.55% 30 Sep 2013
Q2 2013 181 +17.6 +10.8% 30 Jun 2013
Q1 2013 162 +46.3 +40% 31 Mar 2013
Q4 2012 216 31 Dec 2012
Q3 2012 236 30 Sep 2012
Q2 2012 164 30 Jun 2012
Q1 2012 116 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.